Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2511751

O=C(C(NCCc1c[nH]c2ccccc12)c1ccccc1)N1CCc2c(cnc3[nH]ncc23)C1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAT1 O14929 14/20 0.40
EP300 Q09472 14/20 0.40
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.38
SNCA P37840 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12315752 0.96 HAT1 (0.43) HAT1EP300ALDH1A1SNCASMN1; SMN2
Trifluoroacetic Acid SCHEMBL2487091 0.86 DPP8 (0.35) CYP3A4
SCHEMBL2488582 0.81 PDGFRB (0.32) ALDH1A1KDM4ECYP3A4TSHRHSD17B10
Trifluoroacetic Acid SCHEMBL2487366 0.79 ROCK2 (0.46) CYP3A4
SCHEMBL2490206 0.79 HCRTR2 (0.40) ALDH1A1KDM4ELMNATP53MAPK1
SCHEMBL2511753 0.79 SNCA (0.37) ALDH1A1USP2SNCASMN1; SMN2LMNA
SCHEMBL2485351 0.78 ALDH1A1 (0.36) HAT1EP300ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2805666 0.76 SMYD2 (0.41) TP53CYP3A4TSHRTDP1
SCHEMBL2509057 0.73 NAMPT (0.57) ALDH1A1SNCASMN1; SMN2MAPTLMNA
SCHEMBL2486063 0.73 ROCK2 (0.37) ALDH1A1KDM4EMAPTLMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
EP-2379551-A1 SUBSTITUTED PYRAZOLO [3, 4-B]PYRIDINE COMPOUNDS ArQule, Inc. (US) 2011-10-26 EP disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 HAT1 2598/4885EP300 1175/4885ALDH1A1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.